Humacyte, Inc. Files 8-K on Financials
Ticker: HUMAW · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1818382
| Field | Detail |
|---|---|
| Company | Humacyte, Inc. (HUMAW) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, company-update
TL;DR
Humacyte dropped its 8-K with financial updates.
AI Summary
Humacyte, Inc. filed an 8-K on March 28, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. Humacyte, Inc. was formerly known as Alpha Healthcare Acquisition Corp. until a name change on July 16, 2020.
Why It Matters
This filing provides an update on Humacyte's financial performance and condition, which is crucial for investors to assess the company's stability and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Humacyte, Inc. (company) — Registrant
- Alpha Healthcare Acquisition Corp. (company) — Former company name
- March 28, 2025 (date) — Date of report
- July 16, 2020 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Humacyte, Inc.?
The primary purpose is to report on Humacyte, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was Humacyte, Inc. previously known by another name?
Humacyte, Inc. was formerly known as Alpha Healthcare Acquisition Corp. until July 16, 2020.
What is the fiscal year end for Humacyte, Inc.?
The fiscal year end for Humacyte, Inc. is December 31.
In which state was Humacyte, Inc. incorporated?
Humacyte, Inc. was incorporated in Delaware.
What is the business address of Humacyte, Inc.?
The business address of Humacyte, Inc. is 2525 East North Carolina Highway 54, Durham, NC 27713.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding Humacyte, Inc. (HUMAW).